symbol,statement_type,period_end,line_item,value
MEDPLUS.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.180349
MEDPLUS.NS,income,2025-03-31 00:00:00,Normalized EBITDA,5357180000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Total Unusual Items,
MEDPLUS.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
MEDPLUS.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1503220000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,2498430000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,46406600000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,EBITDA,5357180000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,EBIT,2858750000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Net Interest Income,-1025860000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Interest Expense,1025860000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Interest Income,
MEDPLUS.NS,income,2025-03-31 00:00:00,Normalized Income,1503220000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1503220000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Total Expenses,58987930000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
MEDPLUS.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
MEDPLUS.NS,income,2025-03-31 00:00:00,Basic Average Shares,
MEDPLUS.NS,income,2025-03-31 00:00:00,Diluted EPS,
MEDPLUS.NS,income,2025-03-31 00:00:00,Basic EPS,
MEDPLUS.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,1503220000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,1503220000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Net Income,1503220000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Minority Interests,890000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,1502330000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,1502330000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Tax Provision,330560000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Pretax Income,1832890000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,486160000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Special Income Charges,
MEDPLUS.NS,income,2025-03-31 00:00:00,Other Special Charges,
MEDPLUS.NS,income,2025-03-31 00:00:00,Write Off,
MEDPLUS.NS,income,2025-03-31 00:00:00,Impairment Of Capital Assets,
MEDPLUS.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-1025860000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
MEDPLUS.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,1025860000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
MEDPLUS.NS,income,2025-03-31 00:00:00,Operating Income,2372600000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Operating Expense,12581330000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Other Operating Expenses,2822730000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,2498430000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Amortization,
MEDPLUS.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,2498430000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Research And Development,
MEDPLUS.NS,income,2025-03-31 00:00:00,Selling General And Administration,
MEDPLUS.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
MEDPLUS.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
MEDPLUS.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
MEDPLUS.NS,income,2025-03-31 00:00:00,Gross Profit,14953930000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Cost Of Revenue,46406600000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Total Revenue,61360530000.0
MEDPLUS.NS,income,2025-03-31 00:00:00,Operating Revenue,61360530000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.107103
MEDPLUS.NS,income,2024-03-31 00:00:00,Normalized EBITDA,3940900000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Total Unusual Items,38980000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,38980000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,654730000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,2242140000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,43916280000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,EBITDA,3940900000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,EBIT,1698760000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Net Interest Income,-964330000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Interest Expense,964330000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Interest Income,209380000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Normalized Income,654730000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,654730000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Total Expenses,54949870000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,970000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Diluted Average Shares,120133945.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Basic Average Shares,119476277.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Diluted EPS,5.45
MEDPLUS.NS,income,2024-03-31 00:00:00,Basic EPS,5.48
MEDPLUS.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,654730000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,654730000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Net Income,654730000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Minority Interests,-1040000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,655770000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,655770000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Tax Provision,78660000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Pretax Income,734430000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,400080000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Special Income Charges,38980000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Other Special Charges,-41140000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Write Off,2160000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Impairment Of Capital Assets,
MEDPLUS.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-964330000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,
MEDPLUS.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,964330000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,209380000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Operating Income,1298680000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Operating Expense,11033590000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Other Operating Expenses,2536260000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,2242140000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Amortization,18290000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,2242140000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Research And Development,
MEDPLUS.NS,income,2024-03-31 00:00:00,Selling General And Administration,1234120000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,982780000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,General And Administrative Expense,251340000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,970000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Gross Profit,12332270000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Cost Of Revenue,43916280000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Total Revenue,56248550000.0
MEDPLUS.NS,income,2024-03-31 00:00:00,Operating Revenue,56248550000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,11241000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.3
MEDPLUS.NS,income,2023-03-31 00:00:00,Normalized EBITDA,3084780000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Total Unusual Items,37470000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,37470000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,497630000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,1820350000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,35576880000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,EBITDA,3122250000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,EBIT,1301900000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Net Interest Income,-552390000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Interest Expense,830270000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Interest Income,277880000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Normalized Income,471401000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,497630000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Total Expenses,44413480000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,1280000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Diluted Average Shares,119650943.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Basic Average Shares,119305676.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Diluted EPS,4.17
MEDPLUS.NS,income,2023-03-31 00:00:00,Basic EPS,4.17
MEDPLUS.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,497630000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,497630000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Net Income,497630000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Minority Interests,-3420000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,501050000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,501050000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Tax Provision,-29420000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Pretax Income,471630000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,112340000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Special Income Charges,37470000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Other Special Charges,-38550000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Write Off,1080000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Impairment Of Capital Assets,1080000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-552390000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,
MEDPLUS.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,830270000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,277880000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Operating Income,873320000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Operating Expense,8836600000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Other Operating Expenses,934360000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,1815560000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Amortization,17110000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,1798450000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Research And Development,
MEDPLUS.NS,income,2023-03-31 00:00:00,Selling General And Administration,887090000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,677560000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,General And Administrative Expense,209530000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,1280000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Gross Profit,9709920000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Cost Of Revenue,35576880000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Total Revenue,45286800000.0
MEDPLUS.NS,income,2023-03-31 00:00:00,Operating Revenue,45286800000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,7253083.353823
MEDPLUS.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.196934
MEDPLUS.NS,income,2022-03-31 00:00:00,Normalized EBITDA,3000480000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Total Unusual Items,36830000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,36830000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,958020000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,1193600000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,29823750000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,EBITDA,3037310000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,EBIT,1843710000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Net Interest Income,-526960000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Interest Expense,664280000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Interest Income,137320000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Normalized Income,928443083.353823
MEDPLUS.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,958020000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Total Expenses,35987590000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,2530000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Diluted Average Shares,112475398.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Basic Average Shares,112044194.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Diluted EPS,8.52
MEDPLUS.NS,income,2022-03-31 00:00:00,Basic EPS,8.55
MEDPLUS.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,958020000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,958020000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Net Income,958020000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Minority Interests,10680000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,947160000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,947160000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Tax Provision,232270000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Pretax Income,1179430000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,103480000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Special Income Charges,36830000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Other Special Charges,-37090000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Write Off,260000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Impairment Of Capital Assets,260000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-526960000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,
MEDPLUS.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,664280000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,137320000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Operating Income,1566160000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Operating Expense,6163840000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Other Operating Expenses,654680000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,1193600000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Amortization,11240000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,1182360000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Research And Development,
MEDPLUS.NS,income,2022-03-31 00:00:00,Selling General And Administration,642280000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,473480000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,General And Administrative Expense,168800000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,2530000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Gross Profit,7730000000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Cost Of Revenue,29823750000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Total Revenue,37553750000.0
MEDPLUS.NS,income,2022-03-31 00:00:00,Operating Revenue,37553750000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
MEDPLUS.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
MEDPLUS.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
MEDPLUS.NS,income,2021-03-31 00:00:00,Total Unusual Items,24370000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,24370000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
MEDPLUS.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
MEDPLUS.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
MEDPLUS.NS,income,2021-03-31 00:00:00,EBITDA,
MEDPLUS.NS,income,2021-03-31 00:00:00,EBIT,
MEDPLUS.NS,income,2021-03-31 00:00:00,Net Interest Income,
MEDPLUS.NS,income,2021-03-31 00:00:00,Interest Expense,
MEDPLUS.NS,income,2021-03-31 00:00:00,Interest Income,77540000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Normalized Income,
MEDPLUS.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
MEDPLUS.NS,income,2021-03-31 00:00:00,Total Expenses,
MEDPLUS.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,1770000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Diluted Average Shares,119305676.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Basic Average Shares,119305676.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Diluted EPS,5.35247
MEDPLUS.NS,income,2021-03-31 00:00:00,Basic EPS,5.35247
MEDPLUS.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
MEDPLUS.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
MEDPLUS.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
MEDPLUS.NS,income,2021-03-31 00:00:00,Net Income,
MEDPLUS.NS,income,2021-03-31 00:00:00,Minority Interests,
MEDPLUS.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
MEDPLUS.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
MEDPLUS.NS,income,2021-03-31 00:00:00,Tax Provision,
MEDPLUS.NS,income,2021-03-31 00:00:00,Pretax Income,
MEDPLUS.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
MEDPLUS.NS,income,2021-03-31 00:00:00,Special Income Charges,24070000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Other Special Charges,-24770000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Write Off,700000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Impairment Of Capital Assets,700000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
MEDPLUS.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,12280000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
MEDPLUS.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,77540000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Operating Income,
MEDPLUS.NS,income,2021-03-31 00:00:00,Operating Expense,
MEDPLUS.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
MEDPLUS.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
MEDPLUS.NS,income,2021-03-31 00:00:00,Amortization,8130000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
MEDPLUS.NS,income,2021-03-31 00:00:00,Research And Development,2090000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Selling General And Administration,434360000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,292720000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,General And Administrative Expense,141640000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,1770000.0
MEDPLUS.NS,income,2021-03-31 00:00:00,Gross Profit,
MEDPLUS.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
MEDPLUS.NS,income,2021-03-31 00:00:00,Total Revenue,
MEDPLUS.NS,income,2021-03-31 00:00:00,Operating Revenue,
